Detalhe da pesquisa
1.
A Phase 1 dose-escalation study of disulfiram and copper gluconate in patients with advanced solid tumors involving the liver using S-glutathionylation as a biomarker.
BMC Cancer
; 21(1): 510, 2021 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33957901
2.
Phase I/II study of everolimus combined with mFOLFOX-6 and bevacizumab for first-line treatment of metastatic colorectal cancer.
Invest New Drugs
; 37(3): 482-489, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30302599